Adnan Abdul Jabbar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Adnan Abdul Jabbar has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- A. F. M. Kamal Uddin
Radiation Oncology, National Institute of ENT, Dhaka, Bangladesh
1 shared publication - Abhishek Mahajan
Department of Radiology, The Clatterbridge Cancer Centre, Liverpool, United Kingdom
1 shared publication - Amit Dutt
Integrated Cancer Genomics Laboratory, Department of Genetics, University of Delhi South Campus, New Delhi, India
1 shared publication - Anil Tibdewal
Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India
1 shared publication - Anshu Punjabi
Department of Pulmonary Medicine, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, India
1 shared publication - Anuradha Choughule
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
1 shared publication
Latest Publications
- Open Access
- 8 July 2024
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 27, 100430
Uniqueness of lung cancer in Southeast Asia
- 8 July 2024
- Published by Elsevier in The Lancet Regional Health - Southeast Asia
- Vol. 27, 100430
Open AccessUniqueness of lung cancer in Southeast Asia
- Open Access
- 14 December 2022
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 102 (C)
Cardiac sarcoma
Introduction and importance: Primary cardiac sarcoma is a rare malignancy with a poor prognosis because of diagnostic delay, therapeutic difficulties, and high metastatic potential. The therapeutic approach includes surgery, chemotherapy, and radiation therapy, alone or in combination. However, there is a lack of evidence to guide the treatment. Case presentation: We present a case of primary cardiac sarcoma. Our patient was presented in the department of emergency medicine (ED) in our institute with shortness of breath on exertion associated with orthopnea. Based on the history and cardiovascular examination, he underwent an echocardiogram, which revealed a sizeable echogenic density in the right ventricular outflow tract. He underwent surgical resection of the cardiac mass via median sternotomy and total cardiopulmonary bypass approach. The patient was eventually diagnosed with primary cardiac sarcoma, confirmed by tissue biopsy after surgical intervention. Clinical discussion: Through this report, we highlight the rarity of primary cardiac sarcomas, the importance of multidisciplinary tumor board (MDT) discussion and provide evidence of surgical excision being the treatment of choice, followed by systemic chemotherapy in selected cases. Conclusion: Cardiac sarcoma is a rare but highly malignant tumor with a poor prognosis. However, early diagnosis and surgical resection of a primary cardiac sarcoma can significantly increase the patient's survival and quality of life. Therefore, physicians should keep a high suspicion of a patient with clinical features suggestive of cardiac sarcoma, and echocardiography should be the diagnostic modality of choice in such patients. Highlights:
- 14 December 2022
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 102 (C)
Open AccessCardiac sarcoma
Introduction and importance: Primary cardiac sarcoma is a rare malignancy with a poor prognosis because of diagnostic delay, therapeutic difficulties, and high metastatic potential. The therapeutic approach includes surgery, chemotherapy, and radiation therapy, alone or in combination. However, there is a lack of evidence to guide the treatment. Case presentation: We present a case of primary cardiac sarcoma. Our patient was presented in the department of emergency medicine (ED) in our institute with shortness of breath on exertion associated with orthopnea. Based on the history and cardiovascular examination, he underwent an echocardiogram, which revealed a sizeable echogenic density in the right ventricular outflow tract. He underwent surgical resection of the cardiac mass via median sternotomy and total cardiopulmonary bypass approach. The patient was eventually diagnosed with primary cardiac sarcoma, confirmed by tissue biopsy after surgical intervention. Clinical discussion: Through this report, we highlight the rarity of primary cardiac sarcomas, the importance of multidisciplinary tumor board (MDT) discussion and provide evidence of surgical excision being the treatment of choice, followed by systemic chemotherapy in selected cases. Conclusion: Cardiac sarcoma is a rare but highly malignant tumor with a poor prognosis. However, early diagnosis and surgical resection of a primary cardiac sarcoma can significantly increase the patient's survival and quality of life. Therefore, physicians should keep a high suspicion of a patient with clinical features suggestive of cardiac sarcoma, and echocardiography should be the diagnostic modality of choice in such patients. Highlights: